Abstract
Although type 1 diabetes remains the most common type of diabetes in the pediatric population, there has been a dramatic rise in type 2 diabetes in youth. Clinical distinctions between these two major types have become blurred. As genetic and biochemical measures become more affordable and available, practical applications of these measures to better understand diabetes type in youth and the implications of diabetes type on the evolution of the disease are needed.
Similar content being viewed by others
References and Recommended Reading
Green A, Patterson CC: Trends in the incidence of childhood-onset diabetes in Europe 1989–1998. Diabetologia 2001, 4:B3-B8.
Onkamo P, Vaananen S, Karvonen M, Tuomilehto J: Worldwide increase in incidence of type I diabetes—the analysis of the data on published incidence trends. Diabetologia 1999, 42:1395–1403.
SEARCH Study Group: SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004, 25:458–471.
Rocchini AP: Childhood obesity and a diabetes epidemic. N Engl J Med 2002, 346:854–855.
Pinhas-Hamiel O, Dolan LM, Daniels SR, et al.: Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128:608–615.
Scott CR, Smith JM, Cradock MM, Pihoker C: Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics 1997, 100:84–91.
Rosenbloom AL, Joe JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999, 22:345–354.
Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al.: Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000, 136:664–672.
Kaufman FR: Type 2 diabetes in children and youth. Endocrinol Metab Clin North Am 2005, 34:659–676. This is a recent, comprehensive review of type 2 diabetes in children. Also included are major objectives of multicenter studies underway.
Silverstein JH, Rosenbloom AL: Type 2 diabetes in children. Curr Diab Rep 2001, 1:19–27.
Kaufman F, ed: Diabesity: The Obesity-Diabetes Epidemic That Threatens America—and What We Must Do to Stop It. New York, NY: Bantam Doubleday Dell Publishing Group; 2005.
Narayan KMV, Boyle JP, Thompson TJ, et al.: Lifetime risk for diabetes mellitus in the United States. JAMA 2003, 290:1884–1890.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 28:S37-S42.
Fourtner SH, Weinzimer SA, Levitt Katz LE: Hyperglycemic hyperosmolar non-ketotic syndrome in children with type 2 diabetes. Pediatr Diabetes 2005, 6:129–135.
Caprio S, Plewe G, Diamond MP, et al.: Increase insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989, 114:963–967.
Liu LL, Lawrence JM, Liese A, et al.: Prevalence of overweight among US diabetic youth. Diabetes 2005, 54(suppl 1):A450.
American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 2000, 23:381–389.
Liu L, Hironaka K, Pihoker C: Type 2 diabetes in youth. Curr Probl Pediatr Adolesc Health Care 2004, 34:249–280.
O'Brien SH, Holubkov R, Reis EC: Identification, evaluation, and management of obesity in an academic primary care center. Pediatrics 2004, 114:e154-e159.
Graham J, Hagopian WA, Kockum I, et al.: Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002, 51:1346–1355.
Feeney SJ, Myers MA, Mackay IR, et al.: Evaluation of ICA512Ab in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care 1997, 20:1403–1407.
Komulainen J, Kulmala P, Savola K, et al.: Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999, 22:1950–1955.
Hathout EH, Hartwick N, Fagoaga OR, et al.: Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics 2003, 111:860–863.
Notkins AL, Lernmark A: Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001, 108:1247–1252. This is an excellent review of the current status of autoantibodies in diabetes classification.
Winter WE, Harris N, Schatz DA: Type 1 diabetes islet autoantibody markers. Diabetes Technol Ther 2002, 4:817–839.
Kawasaki E, Takino H, Yano M, et al.: Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 1994, 43:80–86.
Hathout EH, Thomas W, El-Shahawy M, et al.: Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001, 107:102–105.
Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C: Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab 2004, 89:2222–2227.
Gilliam LK, Brooks-Worrell BM, Palmer JP, et al.: Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. J Autoimmun 2005, 25:244–250.
Turner R, Stratton I, Horton V, et al.: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 1997, 350:1288–1293. [Published erratum appears in Lancet 1998, 351:376.]
Gilliam KL, Palmer JP, Lernmark A: Autoantibodies and the disease process of type 1 diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text, edn 3. Edited by LeRoith D et al. Philadelphia: Lippincott, Williams, & Wilkins; 2004:499–518.
Palmer JP, Hirsch IB: What's in a name: latent autoimmune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes. Diabetes Care 2003, 26:536–537.
Hampe CS, Kockum I, Landin-Olsson M, et al.: GAD65 antibody epitope patterns of type 1.5 diabetic patients are consistent with slow-onset autoimmune diabetes. Diabetes Care 2002, 25:1481–1485.
Frayling TM, Bulman MP, Ellard S, et al.: Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the UK. Diabetes 1997, 46:720–725.
Sagen JV, Raeder H, Hathout E, et al.: Permanent neonatal diabetes due to mutations in the KDNJ11 encoding Kir6.2. Diabetes 2004, 53:2713–2718.
Gloyn AL, Pearson ER, Antcliff JF, et al.: Activating mutations in the gene encoding the ATP-sensitive potassium channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838–1849.
Shepherd M, Hattersley AT: I don't feel like a diabetic anymore: the impact of stopping insulin in patients with maturity onset diabetes of the young following genetic testing. Clin Med 2004, 4:144–147.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pihoker, C. What type of diabetes do young people have?. Curr Diab Rep 6, 108–112 (2006). https://doi.org/10.1007/s11892-006-0020-0
Issue Date:
DOI: https://doi.org/10.1007/s11892-006-0020-0